Back
Speaker illustration

Doctor Barbara Larcher

0012o00003HdGn8AAF (VIVIT), Feldkirch (Austria)

Presentations

Pro-B-type natriuretic peptide strongly predicts major cardiovascular events and cardiovascular mortality in coronary artery disease patients with NAFLD as well as in those without NAFLD

Event: ESC Congress 2025

Topic: Biomarkers

Session: Risk factors: biomarkers

Access
Like
Thumbnail

The LDL-C/Apo B ratio predicts mortality in heart failure patients both with and without type 2 diabetes

Event: ESC Congress 2025

Topic: Biomarkers

Session: Predicting outcomes and mortality in heart failure

Access
Like
Thumbnail

Health literacy in younger and in older patients with type 2 diabetes undergoing coronary angiography

Event: ESC Congress 2025

Topic: Patient Engagement and Personalised Health

Session: Empowered patients, healthier hearts: a new approach to cardiology

Access
Like
Thumbnail

Type 2 diabetes and the individual perception of risk for cardiovascular death in coronary artery disease patients

Event: ESC Congress 2025

Topic: Patient Engagement and Personalised Health

Session: Predictive analytics in digital health: a new era of risk stratification

Access
Like
Thumbnail

Type 2 diabetes rather than the presence of significant coronary stenoses is associated with quality of life in angiographied coronary patients

Event: ESC Congress 2024

Topic: Public Health

Session: Cardiovascular health: from treatment strategies to lifestyle adherence

Access
Like
Thumbnail

Remnant cholesterol predicts major cardiovascular events in cardiovascular disease patients with NAFLD

Event: ESC Congress 2023

Topic: Lipids

Session: Risk factors and prevention: lipids (5)

Access
Like
Thumbnail

ESC 365 is supported by

bristol-myers-squibb Explore sponsored resources
novartis Explore sponsored resources
novo-nordisk Explore sponsored resources